Herskovits v. Group Health Cooperative
Facts
For purposes of the appeal, the parties assumed that Group Health negligently failed to diagnose Herskovits' lung cancer on his first visit in December 1974. Plaintiff's expert, Dr. Ostrow, testified that if the cancer had been diagnosed then, Herskovits' 5-year survival chance would have been 39 percent, but by the time of diagnosis about 6 months later it had fallen to 25 percent. Thus, the alleged delay reduced his chance of survival by 14 percent, and it was undisputed that he had less than a 50 percent chance of survival at all relevant times. The trial court nonetheless dismissed because plaintiff could not produce expert testimony that earlier diagnosis probably would have prevented death.
Issue
Whether a patient who had less than a 50 percent chance of survival may maintain a professional negligence action when negligent delay in diagnosis reduced that chance of survival by 14 percent. More specifically, the question is whether evidence of a reduced statistical chance of survival is sufficient to let the jury decide proximate cause.
Rule
When a defendant negligently undertakes services necessary to protect another and that negligence increases the risk of harm under Restatement (Second) of Torts § 323(a), evidence that the negligence reduced the patient's chance of survival is sufficient to take proximate cause to the jury. A plaintiff need not prove that timely diagnosis and treatment probably would have produced survival exceeding 50 percent; it is enough to show that the negligence increased the risk of death by reducing a significant chance of survival.
See the holding & full analysis
Create a free KwikCourt account to unlock the rest of this brief — and practice the case.
- The court's holding and reasoning
- Doctrine tests, pitfalls & exam hypotheticals
- 10 practice questions + 4 AI-graded essays on this case
Test yourself
On the defendant's summary judgment motion, what is the strongest argument for denying the motion?